Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Other financing activities (2023 - 2025)

Historic Other financing activities for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $1.0 million.

  • Profound Medical's Other financing activities fell 9504.85% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2024 it was $20.9 million, marking a year-over-year change of. This contributed to the annual value of $4.9 million for FY2024, which is 7647.54% down from last year.
  • According to the latest figures from Q3 2025, Profound Medical's Other financing activities is $1.0 million, which was down 9504.85% from -$89000.0 recorded in Q1 2025.
  • In the past 5 years, Profound Medical's Other financing activities registered a high of $21.9 million during Q2 2024, and its lowest value of -$89000.0 during Q1 2025.
  • For the 3-year period, Profound Medical's Other financing activities averaged around $12.7 million, with its median value being $20.8 million (2023).
  • In the last 5 years, Profound Medical's Other financing activities plummeted by 8540.95% in 2024 and then crashed by 10041.25% in 2025.
  • Quarter analysis of 3 years shows Profound Medical's Other financing activities stood at $20.8 million in 2023, then plummeted by 85.41% to $3.0 million in 2024, then crashed by 65.88% to $1.0 million in 2025.
  • Its Other financing activities was $1.0 million in Q3 2025, compared to -$89000.0 in Q1 2025 and $3.0 million in Q4 2024.